Literature DB >> 2170897

Oncogenic potential of human herpesvirus-6 DNA.

A Razzaque1.   

Abstract

The ability of human herpesvirus-6 (HHV-6, GS strain) DNA to neoplastically transform established NIH3T3 cells was examined. Transfection of NIH3T3 cells with the intact genomic DNA (170 Kb) or the subgenomic clone pZVH14 containing an 8.7 Kb insert followed by focal or G418 selection resulted in the formation of morphologically transformed cells. When injected subcutaneously into nude mice, these cell lines gave rise to rapidly growing tumors while cells transfected with control vector DNA did not grow in agarose and did not produce tumors in mice. By Southern blot analysis, HHV-6 DNA was detected in the G418 selected primary transfectants and tumor cell lines, but not in the focus derived transformed and tumor cell lines. The data suggest that HHV-6 DNA contains sequences which may contribute to neoplastic transformation, but are not likely to be required for maintenance of transformation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2170897

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  18 in total

Review 1.  Human herpesvirus 6.

Authors:  D K Braun; G Dominguez; P E Pellett
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Human herpesvirus 6 and Epstein-Barr virus in Hodgkin's disease: a controlled study by polymerase chain reaction and in situ hybridization.

Authors:  G Valente; P Secchiero; P Lusso; M C Abete; C Jemma; G Reato; S Kerim; R C Gallo; G Palestro
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

3.  Expression of human herpesvirus-6 antigens in benign and malignant lymphoproliferative diseases.

Authors:  M Luppi; P Barozzi; R Garber; A Maiorana; G Bonacorsi; T Artusi; R Trovato; R Marasca; G Torelli
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

Review 4.  Human cytomegalovirus and human herpesvirus 6 genes that transform and transactivate.

Authors:  J Doniger; S Muralidhar; L J Rosenthal
Journal:  Clin Microbiol Rev       Date:  1999-07       Impact factor: 26.132

5.  Identification and characterization of a human herpesvirus 6 gene segment capable of transactivating the human immunodeficiency virus type 1 long terminal repeat in an Sp1 binding site-dependent manner.

Authors:  J Wang; C Jones; M Norcross; E Bohnlein; A Razzaque
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

6.  The evidence of human herpesvirus 6 infection in the lymph nodes of Hodgkin's disease.

Authors:  A Maeda; T Sata; H Enzan; K Tanaka; H Wakiguchi; T Kurashige; K Yamanishi; T Kurata
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

7.  Characterization of the DNA polymerase gene of human herpesvirus 6.

Authors:  I A Teo; B E Griffin; M D Jones
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

8.  Transactivation of the human immunodeficiency virus promoter by human herpesvirus 6 (HHV-6) strains GS and Z-29 in primary human T lymphocytes and identification of transactivating HHV-6(GS) gene fragments.

Authors:  R T Horvat; C Wood; S F Josephs; N Balachandran
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

9.  Activation of the Epstein-Barr virus replicative cycle by human herpesvirus 6.

Authors:  L Flamand; I Stefanescu; D V Ablashi; J Menezes
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

10.  Human herpesvirus 6A ts suppresses both transformation by H-ras and transcription by the H-ras and human immunodeficiency virus type 1 promoters.

Authors:  J C Araujo; J Doniger; F Kashanchi; P L Hermonat; J Thompson; L J Rosenthal
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.